Mostrar registro simples

dc.contributor.authorPoletto, Édinapt_BR
dc.contributor.authorMatte, Ursula da Silveirapt_BR
dc.contributor.authorBaldo, Guilhermept_BR
dc.date.accessioned2021-05-19T04:32:04Zpt_BR
dc.date.issued2018pt_BR
dc.identifier.issn1471-2350pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/221268pt_BR
dc.description.abstractIn this comment, we highlight that the IDUA pathogenic variants 704ins5 and c.613_617dupTGCTC are the same, but have different names depending on the nomenclature guideline used. Therefore, the frequency of this variant is 17.6% of alleles in Korean patients. This commentary stresses the importance of proper variant annotation and the use of guidelines when describing or reviewing mutations.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofBMC medical genetics. London. Vol. 19 (2018), Article number 180, p. 1-2pt_BR
dc.rightsOpen Accessen
dc.subjectIDUAen
dc.subjectMutação genéticapt_BR
dc.subjecta-L-iduronidasept_BR
dc.subject704ins5en
dc.subjectMucopolissacaridose Ipt_BR
dc.subjectC.613_617dupTGCTCen
dc.subjectCoréiapt_BR
dc.subjectChinapt_BR
dc.subjectJapãopt_BR
dc.titleComment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”pt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001101789pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples